Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to <it>Candida albicans </it>infection

1471-2334-9-98 1471-2334 Research article Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to <it>Candida albicans </it>infection Camargo R Marcela marcelarc@fc.unesp.br Venturini James james@fc.unesp.br Vilani-Moreno R Fátima fmoreno@ilsl.br Arruda Sueli P Maria sueli@fc.unesp.br

Experimental Immunopathology Laboratory, Department of Biological Sciences, College of Sciences, São Paulo State University, UNESP, Bauru, SP, 17047-001, Brazil

Botucatu Medical School, São Paulo State University, UNESP, Botucatu, SP, 18618-970, Brazil

Instituto Lauro de Souza Lima, Bauru, SP, 17034-971, Brazil

BMC Infectious Diseases 1471-2334 2009 9 1 98 http://www.biomedcentral.com/1471-2334/9/98 19534779 10.1186/1471-2334-9-98 08 12 2008 17 6 2009 17 6 2009 2009 Camargo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

In order to attain a better understanding of the interactions between opportunist fungi and their hosts, we investigated the cytokine profile associated with the inflammatory response to Candida albicans infection in mice with solid Ehrlich tumors of different degrees.

Methods

Groups of eight animals were inoculated intraperitoneally with 5 × 10⁶C. albicans 7, 14 or 21 days after tumor implantation. After 24 or 72 hours, the animals were euthanized and intraperitoneal lavage fluid was collected. Peritoneal macrophages were cultivated and the levels of IFN-γ, TNF-α, IL-12, IL-10 and IL-4 released into the supernatants were measured by ELISA. Kidney, liver and spleen samples were evaluated for fungal dissemination. Tumor-free animals and animals that had only been subjected to C. albicans infection were used as control groups.

Results

Our results demonstrated that the mice produced more IFN-γ and TNF-α and less IL-10, and also exhibited fungal clearance, at the beginning of tumor evolution. With the tumor progression, this picture changed: IL-10 production increased and IFN-γ and TNF-α release decreased; furthermore, there was extensive fungal dissemination.

Conclusion

Our results indicate that solid tumors can affect the production of macrophage cytokines and, in consequence, affect host resistance to opportunistic infections.

Background

Systemic Candida albicans infections have a marked impact on the clinical course and outcome of cancer patients 12; they are responsible for prolonged hospital stays, high healthcare costs and significant mortality 3456. Although a compromised immune response has been invoked as a cause of susceptibility to major infections in tumor-bearing patients, some authors disagree, arguing that the tumoral condition may, inter alia, result in active protection against opportunist pathogens 7. As most knowledge about Candida infections in cancer patients has been obtained from patients with hematological malignancies 8, and since candidemia is an important complication in patients with solid tumors, we decided to study this premise using peritoneal macrophages in mice bearing solid Ehrlich tumors and infected with C. albicans. Previous studies have suggested an important role for macrophages in the control of candidiasis 910. Those cells recognizably have a critical role in innate immunity and in the polarization of the immune adaptive response. They express complex functions including the production of cytokines that modulate the responses of other immune system cells and themselves as well, and bactericidal/tumoricidal activities 8. Thus, if macrophage activities are compromised, the host may become more susceptible to infections and tumors and this may prejudice the results of specific treatments. The peritoneal macrophage population was chosen on the basis of the report of Bhaumik et al. 11 about macrophage traffic between the peritoneum and neoplastic tissues. According to those authors, during the evolution of the neoplasm, macrophages originating from the tumor will lodge within the peritoneal cavity.

Numerous studies have described a significant decrease in macrophage functions in tumor-bearing hosts 7. Since we found no account in the literature about the role of cytokines in the development of solid tumors, and since there are divergent views about the evolution and gravity of C. albicans infection under such circumstances, we proposed to investigate those questions, evaluating the kinetics of cytokine production in mice that bore solid Ehrlich tumors (BTM) and were infected or not infected with the fungus.

Methods

Animals

Male Swiss mice (two months old) from the Animal House of São Paulo State University, Botucatu, SP, Brazil, were housed in groups of 3–5 animals and were provided with food and water ad libitum. All the protocols accorded with the ethical principles for animal research adopted by the Brazilian College of Animal Experimentation (COBEA). This study was approved by Ethical Committee of School of Sciences, Sao Paulo State University.

Experimental design

The mice were divided into four groups: two BTM groups inoculated or not inoculated with C. albicans (Ca-BTM and BTM, respectively); and two control groups, tumor-free mice that were inoculated or not inoculated with C. albicans (Ca-CTL and CTL, respectively). The BTM group animals were killed on days 7, 14 or 21 after tumor implantation. The Ca-BTM group animals were inoculated intraperitoneally (i.p.) with C. albicans (5 × 10⁶fungi) on days 7, 14 or 21 after tumor implantation and were killed 24 or 72 h after C. albicans inoculation. Finally, the Ca-CTL group animals were sacrificed 24 or 72 h after C. albicans inoculation.

Ehrlich solid tumor (EST)

This neoplasia, a spontaneous mammary tumor in mice, does not resolve spontaneously. It may evolve to ascitic (EAT) or solid forms depending on the route of inoculation (intraperitoneal or subcutaneous respectively). In this study, the tumor was maintained in the ascitic form in Swiss mice and the cells were collected according to Silva et al. 12. Tumor cells (1 × 10⁷/100 μl) were inoculated subcutaneously into both the BTM and Ca-BTM groups.

C. albicans inoculum

C. albicans strain FCF 14 was originally obtained from the fungal collection of the School of Odontology, São Paulo State University, São Jose dos Campos, SP, Brazil. The fungi were maintained on Sabouraud medium (Difco Laboratories, Detroit, Michigan, USA), then cultured in the same medium for 24 h at 37°C. The colonies were resuspended and washed twice. Fungal viability was determined by cotton blue staining and the concentration was adjusted to 5 × 10⁷viable C. albicans/ml 13.

Collection of the biological material and macrophage culture

Mice were sacrificed using CO₂euthanasia, and peritoneal cells were collected by washing the peritoneal cavity with 10 ml ice-cold sterile phosphate buffered saline (PBS), pH 7.4. The suspension was centrifuged and the cells were resuspended in 1 ml RPMI-1640 (Nutricell, Campinas, SP, Brazil) containing 10% heat-inactivated fetal calf serum (Gibco BRL, Grand Island, NY, USA). The cell concentration was adjusted to 2 × 10⁶macrophages/ml, as judged by the uptake of 0.02% neutral red. The peritoneal cells were placed in 96-well flat-bottom microtiter plates (Costar, Cambridge, MA, USA) and incubated for 2 h at 37°C and 5% CO₂in a humidified chamber to allow macrophages to adhere and spread. Non-adherent cells were removed by washing the wells three times with RPMI, and the remaining adherent cells (>97% macrophages as assessed by morphological examination) were used for experiments. The macrophages were cultured at 37°C, 5% CO₂, in RPMI-1640 with or without 10 μg/ml LPS (Sigma) as an internal control for macrophage activity (data not shown). After 24 h, the cell-free supernatants were harvested and stored at -70°C pending cytokine analysis. Finally, the peritoneal fluid and liver, spleen and kidney fragments were subjected to microbiological evaluation.

Direct organ culture

Ten fragments (2 × 2 mm) of liver, spleen and kidney were placed on 15 × 90 mm Sabouraud agar plates at 37°C for 5 days according to a previously-described method 14. The yeast colonies on the fragments were counted and the results were expressed as the frequency of Candida-positive organ fragments.

Fungal loads in PF

PF (30 μl) was placed on 15 × 90 mm Sabouraud agar plates at 37°C. The yeast colonies were counted on the 5^thday and the fungal loads were determined by counting the colony-forming units (CFU).

Cytokine analysis

TNF-α, IL-12, IFN-γ, IL-10 and IL-4 levels were measured in the cell-free supernatants of the peritoneal cell cultures using a Cytokine Duo-Set Kit (R&D Systems, Minneapolis, USA). Each sample was analyzed in duplicate.

Statistical analysis

Linear regression analysis was used to determine the correlation between tumor evolution and fungal installation and dissemination. Cytokine production data were analyzed using one-way ANOVA with the Tukey-Kramer post-test 15. All statistical tests were conducted using GraphPad InStat version 3.0 for Windows (GraphPad Software, San Diego, California, USA) and p < 0.05 was taken as the criterion for statistical significance.

Results

Tumor implant

After the EAT cells were introduced in the subcutaneous tissue (EST), the mice developed at the inoculation site a firm, tangible, whitish coloring and relatively movable mass. This tumor showed continuous and progressive growth, leading to the death of the animals at about the 25th day after implantation.

Fungi installation and dissemination

CTL and BTM animals showed no fungi in any of the samples analyzed or at any time during the experiment.

The frequencies of C. albicans-positive animals in the Ca-CTL and Ca-BTM groups are summarized in Table 1. In the Ca-CTL group, intraperitoneal introduction of the fungus resulted in acute systemic candidiasis, with dissemination to the spleen, liver and kidneys. At 72 h, the frequency of C. albicans-positive samples decreased, both internally and at the inoculation site, suggesting a tendency towards resolution. In the Ca-BTM group, only one animal after seven days of tumor evolution was Candida-positive 24 h pi. At 14 days of tumor evolution, the animals presented a similar picture to the control group. At 21 days, we observed that all the mice showed fungi, but there was exacerbation; the cultivation of tissue samples revealed more viable fungi than in the control group animals [data not shown]. We observed a positive correlation between tumor evolution and the frequency of PF and/or organ colonization after 72 h (r = 0.99; p = 0.04).

Table 1

Frequency of Candida albicans-positive animals from the Ca-CTL and TBM-Ca groups^a.

Experimental Group

Candida infection hours

Organs^b

Peritoneum

Spleen

Kidney

Liver

Ca-CTL

91.7 ± 14.4

80.3 ± 14.4

48.3 ± 44.8

8.3 ± 14.8

50.0 ± 0

66.7 ± 28.9

8.3 ± 14.8

Ca-TBM

7^thday

25.0 ± 0

8.3 ± 14.8

Ca-TBM

14^thday

100.0 ± 0

91.7 ± 14.4

33.3 ± 14.4

8.3 ± 14.8

50.0 ± 25.0

58.3 ± 28.9

25.0 ± 25.0

25.0 ± 0

Ca-TBM

21^thday

100.0 ± 0

66.7 ± 14.4

41.7 ± 52.0

25.0 ± 25.0

75.0 ± 0

75.0 ± 25.0

50.0 ± 25.0

58.3 ± 28.9

^aThe results shown are the average of triplicate experiment. For each experiment, four animals per group were used.

^bData expressed as mean frequency of Candida-positive animals (%) ± SD.

Cytokine determination

In the present study, IL-12 production was only observed in Ca-CTL at 24 h (5.44 ± 1.95 pg/ml).

The level of TNF-α in Ca-CTL increased at 24 h and decreased at 72 h pi (Fig. 1). In BTM, levels of this cytokine increased initially, but decreased with the tumor progression (Fig. 2). A challenge with C. albicans (Ca-BTM group) did not change this picture: TNF-α increased during the first period of tumor progression, but there was a decrease at 72 h pi after the 14^thday (Fig. 3).

Figure 1

Release of TNF-α, IFN-γ and IL-10 spontaneously produced by peritoneal macrophages in the Ca-CTL group

Release of TNF-α, IFN-γ and IL-10 spontaneously produced by peritoneal macrophages in the Ca-CTL group. Data are expressed as mean ± SEM. * significantly different from CTL, ^#vs. Ca-CTL 24 h. P < 0.05; n = 4/group. ANOVA; Tukey's post-test.

Figure 2

Release of TNF-α, IFN-γ and IL-10 spontaneously produced by peritoneal macrophages in the TBM group

Release of TNF-α, IFN-γ and IL-10 spontaneously produced by peritoneal macrophages in the TBM group. Data are expressed as mean ± SEM. * significantly different from CTL, ^#vs. BTM 7^thday; ^§vs. TBM 14^thday. P < 0.05; n = 4/group. ANOVA; Tukey's post-test.

Figure 3

Release of TNF-α, IFN-γ and IL-10 spontaneously produced by peritoneal macrophages in the Ca-TBM group

Release of TNF-α, IFN-γ and IL-10 spontaneously produced by peritoneal macrophages in the Ca-TBM group. Data are expressed as mean ± SEM. * significantly different from TBM, ^#vs. Ca-CTL. P < 0.05; n = 4/group. ANOVA; Tukey's post-test.

To evaluate the immune protective response, we investigated INF-γ production. In our study, macrophages from Ca-CTL group mice showed an increase in IFN-γ production 24 h pi as at 72 h pi (Fig. 1). Although the IFN-γ levels at 72 h remained higher than in the controls, they were significantly lower than those obtained at 24 h (Fig. 1). This datum correlates positively with the fungal concentration in the peritoneal environment, i.e. higher at 24 h than at 72 h. BTM macrophages showed increased IFN-γ production only at the 7^thday of tumor progression (Fig. 2). In Ca-BTM, the quantity of IFN-γ measured was higher at the 7^thand 14^thdays of tumor progression (Fig. 3).

To evaluate the anti-inflammatory immune response, we investigated IL-4 and IL-10 production. With rare exceptions, we found no IL-4 in our animals. We verified that the peritoneal macrophages of CTL mice (stimulus-free) could produce IL-10. After inoculation with the fungus, the production of this cytokine decreased at 24 h and returned to base level at 72 h pi (Fig 3A). BTM mice showed a significant increase in IL-10 production throughout tumor progression. In the Ca-BTM group, this cytokine decreased after 7 and 14 days of tumor progression (Fig. 3); at 21 days it increased 24 and 72 h after Candida infection.

Taken together, our results show that at the outset of tumor progression, BTM group animals produced large quantities of TNF-α and IFN-γ and little IL-10, and they showed fungal clearance. With the tumor progressed, this picture changed: IL-10 production increased and TNF-α and IFN-γ production decreased, and the animals showed extensive fungal dissemination. Our results also indicate that the tumoral condition suppressed the production of macrophage cytokine IL-12.

Discussion

Deterioration of immune function and an increased incidence and lethality of infectious diseases caused by Candida albicans have been observed in tumor patients 1617. Although the mechanisms involved in this association are not totally clear, macrophages are known to play a significant part.

We studied this association in mice with EST, a spontaneous mammary mice tumor of which the development has been related to the activity of the immune system. In a previous study we verified that this tumor significantly decreased the overall resistance of mice to systemic C. albicans infection and that this effect was associated with alterations in the oxidative metabolic activity of peritoneal macrophages 18. As cytokines are deeply involved in both processes (host immunosurveillance against invading pathogens and malignancies), we investigated the possibility that the tumoral condition affects the profile of cytokines released by peritoneal macrophages from tumor-bearing and/or C. albicans-infected mice. We studied the expression of IFN-γ and IL-12, the major cytokines produced by macrophages and crucial for a vigorous immune response 19. We also evaluated the production of IL-10 and IL-4, strong inhibitors of macrophage activation and the inflammatory response 20212223.

We began the study by identifying the cytokines produced by peritoneal macrophages from normal mice (CTL group). We verified that, although incapable of producing IL-12 or IL-4, those cells produced negligible quantities of IFN-γ and significantly more IL-10 than other cytokines. Thus, as observed in rodent strains and also in humans, resident peritoneal macrophage from Swiss mice bear some similarities to the M2 subtype, which typically produce IL-10 242526.

Compared with resident peritoneal cells from animals of CTL group, the macrophages from Candida-infected mice (Ca-CTL group) produced less IL-10 but copious amounts of IFN-γ and IL-12. The capacity to elaborate high levels of IL-12 and low levels of IL-10 is characteristic of M1 macrophages 27. M1 macrophages are strong promoters of Th1 immune responses and exert antimicrobial activities, resulting from their ability to secrete reactive nitrogen and oxygen species (NO, peroxynitrite, hydrogen peroxide, superoxide) 19. In fact, in this microenvironment, the fungal load is obliterated or is markedly reduced. In the absence of fungi, the peritoneal macrophages exhibited the M2 profile again.

Thus, the introduction of C. albicans into the peritoneal environment leads to changes of the macrophage phenotype. In agreement with other studies, this reinforces the idea that, even when polarized, Swiss peritoneal macrophages can integrate different signals adequately and can convert their phenotype from M2 to M1 and vice versa.

Tumor progression also provoked alterations that changed the peritoneal macrophage profile: at the outset of the neoplastic process, BTM peritoneal macrophages demonstrated consistent TNF-α production and moderate IFN-γ and IL-10 production. Thus, either they exhibited a functionally mixed population or adopted a rather promiscuous activation state, which could however be ideally suited for diminishing tumor immunosurveillance 28.

With the tumor progressed, the macrophages showed a profile similar to the M2 population. At this time, they became refractory to further stimulation; even when provoked with C. albicans, they persisted in exhibiting an immunosuppressive phenotype and could not mount an effective anti-fungal response. These results support the findings of Kuang et al. 29, who suggest that new stimuli can fail to stimulate pre-activated cells and subsequently exhausted monocytes/macrophages.

The fact that those phenomena occurred at a site distant from the neoplastic mass indicates that the solid Ehrlich tumor provokes alterations in systemic levels. This may have occurred because of mediators derived from tumor cells and/or of derivative elements in the tumor stroma 293031323334. It is still possible that, along of the progression of the neoplasm, we have collected macrophages originating from a tumor itself. Working with the subcutaneous variety of AK-5, a histiocytic rat tumor, Bhaumik et al. 11 demonstrated hyperactive macrophages accumulated in the peritoneum during tumor progression, and the number of those macrophages decreased drastically when the tumor regressed. Direct labeling of these cells with vital dyes showed that they migrated to and from the tumor site.

From Kuang et al. 29, macrophages recruited into the cancer from the circulation may be transiently activated while approaching the stroma surrounding the tumor. When they are in close proximity to the tumor cells, tumor-derived factors would act on them, inducing the M2 phenotype 35. Our results showed similarities with this assertion, since after seven days of tumor evolution we detected a mixed population of peritoneal macrophages, including pro-inflammatory ones, and with the tumor progression, this population re-acquired a predominantly pro-tumoral M2 subset. As those macrophages have no microbicid profile, they turn the peritoneal cavity into a microenvironment favorable for persistent infection. In fact, with the tumor progression, the animals become more susceptible to Candida, as shown by its permanence at the inocolum site, and its dissemination is facilitated.

Conclusion

Our results showed that at the outset of tumor progression, the mice produced more IFN-γ and TNF-α and less IL-10; they also exhibited fungal clearance. With the tumor progression, this picture changed: IL-10 production increased and IFN-γ and TNF-α release decreased; furthermore, there was extensive fungal dissemination. This picture indicates that solid tumor progression modulates the cytokine profile of peritoneal macrophages, possibly because tumor macrophages continually enter the circulation; a development that may compromise the systemic immune response.

Abbreviations

TBM: tumor-bearing mice; COBEA: Brazilian College of Animal Experimentation; Ca-TBM: tumor-bearing mice that were inoculated with C. albicans; Ca-CTL: mice inoculated only with C. albicans; CTL: tumor-free mice and not inoculated with C. albicans; EST: Ehrlich solid tumor; EAT: Ehrlich ascetic tumor; PF: peritoneal fluid; CFU: colony-forming units.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MRC performed the laboratory assays, participated in the sequence alignment, and drafted the manuscript. JV carried out the laboratory assays and performed the statistical analysis. FRVM participated in the immunogical evaluations. MSPA conceived the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We are grateful to FAPESP for financial support.

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials Elting LS Rubenstein EB Rolston KV Bodey GP Clin Infect Dis 1997 25 247 259 10.1086/514550 9332520 Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study Wisplinghoff H Cornely OA Moser S Bethe U Stützer H Salzberger B Fätkenheuer G Seifert H Infect Control Hosp Epidemiol 2003 24 905 911 10.1086/502158 14700405 Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematologic malignancies and solid neoplasms in hospitals in the United States Wisplinghoff H Seifert H Wenzel RP Edmond MB Clin Infect Dis 2003 36 1103 1110 10.1086/374339 12715303 Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital Jugo J Kennedy R Crowe MJ Lamrock G McClurg RB Rooney PJ Morris TC Johnston PG J Hosp Infect 2002 50 48 55 10.1053/jhin.2001.1101 11825052 Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center Velasco E Byington R Martins CA Schirmer M Dias LM Gonçalves VM Eur J Clin Microbiol Infect Dis 2003 22 137 143 12649710 Candidaemia and cancer: patients are not all the same Pasqualotto AC Rosa DD Medeiros LR Severo LC BMC Infect Dis 2006 6 50 1431538 16542444 10.1186/1471-2334-6-50 Role of polymorphonuclear leukocytes in the resistance of tumor-bearing mice against Candida albicans infection Okawa Y Kobayashi M Sakai K Suzuki M Biol Pharm Bull 2004 27 674 678 10.1248/bpb.27.674 15133243 Modulation of ros/no production by murine peritoneal macrophages in response to bacterial CpG DNA stimulation Olishevsky S Burlaka A Sidorik E Shlyakhovenko V Garpenko Y Kozak V Exp Oncol 2006 28 114 120 16837901 Stress, immunity and mycotic diseases Mishra SK Segal E Gunter E Kurup VP Mishra J Murali PS Pierson DL Sandovsky-Losica H Stevens DA J Med Vet Mycol 1994 32 379 400 10.1080/02681219480000981 7722800 Early resistance Interleukin-10 knockout mice to acute systemic candidiasis Vazquez-Torres A Jones-Carson J Wagner RD Warner T Balish E Infect Immun 1999 67 670 674 96371 9916075 Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking Bhaumik S Mitra R Varalakshmi C Khar A Exp Cell Research 2001 266 44 52 10.1006/excr.2001.5201 Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom Silva RJ Silva MG Vilela LC Fecchio D Mediators Inflamm 2002 11 197 201 1781666 12396470 10.1080/0962935029000041 Candidíase Experimental: estudo comparativo de dois Métodos de coloração vital na determinação da viabilidade dos fungos em suspensão Vilani-Moreno FR Arruda MSP Escudeiro H Salusvita 1999 18 139 142 Isolation of <it>Paracoccidioides brasiliensis </it>from armadillos (<it>Dasypus noveminctus</it>) captured in an endemic area of paracoccidioidomycosis Bagagli E Sano A Coelho KI Alquati S Miyaji M de Camargo ZP Gomes GM Franco M Montenegro MR Am J Trop Med Hyg 1998 58 505 512 9574800 Zar JH Biostatistical Analysis New Jersey: Prentice Hall 1999 Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades Safdar A Perlin DS Armstrong D Diagn Microbiol Infect Dis 2002 44 11 16 10.1016/S0732-8893(02)00423-6 12376025 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Ascioglu S Clin Infect Dis 2002 34 7 14 10.1086/323335 11731939 Influence of tumor condition on the macrophage activity in <it>Candida albicans </it>infection Venturini J Camargo MR Vilani-Moreno FR Arruda MSP Scand J Immunol 2009 70 10 17 10.1111/j.1365-3083.2009.02260.x 19522762 Inflammatory cytokines and antigen presenting cell activation Murtaugh MP Foss DL Vet Immunol Immunopathol 2002 87 109 121 10.1016/S0165-2427(02)00042-9 12072225 Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance Berg DJ Kühn R Rajewsky K Müller W Menon S Davidson N Grünig G Rennick D J Clin Invest 1995 96 2339 2347 185885 7593621 10.1172/JCI118290 IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice Bettelli E Das MP Howard ED Weiner HL Sobel RA Kuchroo VK J Immunol 1998 161 3299 3306 9759845 The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis Fuss IJ Boirivant M Lacy B Strober W J Immunol 2002 168 900 908 11777988 Interleukin-10-deficient mice develop chronic enterocolitis Kühn R Löhler J Rennick D Rajewsky K Müller W Cell 1993 75 263 274 10.1016/0092-8674(93)80068-P 8402911 The chemokine system in diverse forms of macrophage activation and polarization Mantovani A Sica A Sozzani S Allavena P Vecchi A Locati M Trends Immunol 2004 25 677 686 10.1016/j.it.2004.09.015 15530839 Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type Xu W Schlagwein N Roos A Berg van den TK Daha MR van Kooten C Eur J Immunol 2007 37 1594 1599 10.1002/eji.200737042 17474153 A distinct and unique transcriptional programme expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) Biswas SK Blood 2006 107 2112 2122 10.1182/blood-2005-01-0428 16269622 Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria Verreck FA Proc Natl Acad Sci USA 2004 101 4560 4565 384786 15070757 10.1073/pnas.0400983101 Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion Van Ginderachter JA Movahedi K Hassanzadeh Ghassabeh G Meerschaut S Beschin A Raes G De Baetselier P Immunobiology 2006 211 487 501 10.1016/j.imbio.2006.06.002 16920488 Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes Kuang DM Wu Y Chen N Cheng J Zhuang SM Zheng L Blood 2007 110 587 595 10.1182/blood-2007-01-068031 17395778 Tumor-induced immune dysfunction: the macrophage connection Elgert KD Alleva DG Mullins DW J Leukoc Biol 1998 64 275 290 9738653 Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future Argilés JM Busquets S García-Martínez C López-Soriano FJ Nutrition 2005 21 977 985 16043325 Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism McKee CM Lowenstein CJ Horton MR Wu J Bao C Chin BY Choi AM Noble PW J Biol Chem 1997 272 8013 8018 10.1074/jbc.272.12.8013 9065473 Aspectos morfológicos e funcionais de macrófagos peritoneais de animais portadores de tumor de Walker-256 Bracht L PhD thesis Paraná Federal University, Biological Sciences Departament 2006 Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor-derived factors Lopez DM Handel-Fernandez ME Cheng X Charyulu V Herbert LM Dinapoli MR Calderon CL Anticancer Res 1996 16 6C 3923 9 9042314 Macrophages direct tumour histology and clinical outcome in a colon cancer model Oosterling SJ Bij van der GJ Meijer GA Tuk CW van Garderen E van Rooijen N Meijer S Sijp van der JR Beelen RH van Egmond M J Pathol 2005 207 147 155 10.1002/path.1830 16104052

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/9/98/prepub